21428726

Source:http://linkedlifedata.com/resource/pubmed/id/21428726

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:21428726	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:21428726	lifeskim:mentions	umls-concept:C2349001	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0681850	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C1706203	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C2697811	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0005682	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0878773	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C1280500	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C2343853	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C1550501	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0681906	lld:lifeskim
pubmed-article:21428726	lifeskim:mentions	umls-concept:C0439230	lld:lifeskim
pubmed-article:21428726	pubmed:issue	5	lld:pubmed
pubmed-article:21428726	pubmed:dateCreated	2011-4-15	lld:pubmed
pubmed-article:21428726	pubmed:databankReference	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21428726	pubmed:abstractText	To assess the onset of efficacy of fesoterodine 4 mg versus placebo in subjects with overactive bladder (OAB) symptoms.	lld:pubmed
pubmed-article:21428726	pubmed:language	eng	lld:pubmed
pubmed-article:21428726	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21428726	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:21428726	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21428726	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:21428726	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:21428726	pubmed:month	May	lld:pubmed
pubmed-article:21428726	pubmed:issn	1473-4877	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:CorcosJacques...	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:GarelyAlan...	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:CarlssonMarti...	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:GuanZhonghong...	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:GongJasonJ	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:AnguloJavier...	lld:pubmed
pubmed-article:21428726	pubmed:author	pubmed-author:Fesoterodine...	lld:pubmed
pubmed-article:21428726	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:21428726	pubmed:volume	27	lld:pubmed
pubmed-article:21428726	pubmed:owner	NLM	lld:pubmed
pubmed-article:21428726	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:21428726	pubmed:pagination	1059-65	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:meshHeading	pubmed-meshheading:21428726...	lld:pubmed
pubmed-article:21428726	pubmed:year	2011	lld:pubmed
pubmed-article:21428726	pubmed:articleTitle	Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder.	lld:pubmed
pubmed-article:21428726	pubmed:affiliation	Department of Urology, Jewish General Hospital, Montreal, QC, Canada. jcorcos@jgh.mcgill.ca	lld:pubmed
pubmed-article:21428726	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:21428726	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:21428726	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:21428726	pubmed:publicationType	Multicenter Study	lld:pubmed